A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Metastasis requires epithelial-mesenchymal transition (EMT) enabling local invasion, intravasation into vessels, survival in circulation, extravasation, and colonization of distant sites. Most disseminated cancer cells die; only ~0.01% establish metastatic colonies.
Study the invasion-metastasis cascade step-by-step. Understand EMT transcription factors (Snail, Slug, Twist) and loss of E-cadherin. Review the seed-and-soil hypothesis: tumor cells preferentially colonize permissive microenvironments.
Metastatic potential is not predetermined—it emerges through selection for aggressive clones. Circulating tumor cells (CTCs) are not synonymous with metastasis; most are eliminated without establishing colonies.
From your study of carcinogenesis, you know that cancer is an evolutionary process: cells accumulate mutations, and natural selection within the tumor microenvironment favors those that proliferate most effectively. Metastasis is the endpoint of a further selection — for cells that can survive not just in the primary tumor but in entirely foreign environments. Understanding this as a selective process rather than a programmed fate changes how you interpret the cascade.
The first challenge for a tumor cell attempting to metastasize is architectural. Epithelial cells, which give rise to most carcinomas, are built to stay put — they express E-cadherin, a surface protein that glues cells to their neighbors, and they depend on a fixed basement membrane for survival signals. To leave the primary tumor, a cancer cell must undergo epithelial-mesenchymal transition (EMT): a transcriptional reprogramming (driven by factors like Snail, Slug, and Twist) that downregulates E-cadherin and upregulates mesenchymal markers like vimentin. The cell becomes loosely attached, motile, and capable of dissolving extracellular matrix using metalloproteinases — the biological equivalent of turning from a brick in a wall into an independent agent.
Intravasation — entering the bloodstream or lymphatics — is the next barrier. Tumor cells must penetrate the endothelial wall of nearby vessels. Once in circulation, they face a hostile environment: immune surveillance, shear forces, and the absence of survival signals from matrix contacts (anoikis). The vast majority of circulating tumor cells (CTCs) are eliminated here. The ~0.01% that survive often do so by clustering with platelets, which shield them from immune detection and provide survival signals. Extravasation at a distant site requires a second round of endothelial penetration.
Even after a cell arrives at a distant site, establishing a metastatic colony requires a permissive microenvironment — what Paget's 1889 "seed and soil" hypothesis described. Breast cancer preferentially seeds bone, lung, brain, and liver for reasons that reflect specific molecular affinities: breast cancer cells express receptors for chemokines secreted by bone marrow stromal cells (e.g., CXCL12/CXCR4 axis). Once lodged, some cells remain dormant for years before reactivating — a clinical challenge because adjuvant therapy given at the time of primary surgery may not eliminate these micrometastases, which then emerge as recurrence a decade later. This dormancy and late reactivation is why the metastatic capacity of a tumor cannot be fully judged at diagnosis.